BI-1347

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBI-1347
Drug Alias NameBI-1347
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 8 inhibitors
TargetsCyclin-dependent kinase 8
Therapy Area/IndicationsBreast NeoplasmsMelanomaLymphoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBoehringer Ingelheim Ltd
Inactive CompaniesN/A
Active IndicationsBreast NeoplasmsMelanomaLymphoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A